About
Stem Cell Therapy
Areas of Focus
Categories
Stem Cell & Cellular TherapyMiddle East
Clinical Trials (9)
View allTotal Trials
9
As Lead Sponsor
8
As Collaborator
1
Total Enrollment
290
By Phase
PHASE1/PHASE2: 5PHASE3: 2PHASE2: 1
By Status
COMPLETED: 7TERMINATED: 2
Clinical Trials Pipeline9 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT05296525Lead Sponsor
Evaluation of Safety and Efficacy of Allo GDA-201 Natural Killer (NK) Cells in Patients With Relapsed/Refractory B Cell NHL
PHASE1/PHASE2Terminated
13 participants
Started: Jul 5, 2022 · Completed: Apr 22, 2024
NCT04260698Lead Sponsor
Expanded Access of Omidubicel, for Allogeneic Transplantation in Patients With Hematological Malignancies
PHASE3Completed
36 participants
Started: Jul 8, 2020 · Completed: May 8, 2025
NCT02730299Lead Sponsor
Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS
PHASE3Completed
125 participants
Started: Dec 16, 2016 · Completed: Feb 7, 2025
NCT02504619Lead Sponsor
Allogeneic SCT of CordIn™, in Patients With Hemoglobinopathies
PHASE1/PHASE2Terminated
1 participants
Started: Apr 4, 2016 · Completed: Dec 31, 2017
NCT02039557Lead Sponsor
Long Term Follow Up Protocol for NiCord®/CordIn™ (Omidubicel) Patients
N/ACompleted
33 participants
Started: May 1, 2014 · Completed: Jun 29, 2023
Locations (1)
Headquarters
Kiryat Gat, Israel
Map
Loading map...